Silofast Capsule 4 mg contains Silodosin, a selective alpha-1 adrenergic receptor antagonist used in the management of benign prostatic hyperplasia (BPH). BPH is a common condition in men over 50, characterized by an enlarged prostate that obstructs urine flow, causing symptoms such as difficulty in starting urination, weak stream, frequent urination, urgency, and nocturia. Silodosin works by relaxing the smooth muscles in the prostate gland, bladder neck, and urethra, making it easier to urinate and relieving lower urinary tract symptoms (LUTS) associated with BPH.
The 4 mg formulation is typically prescribed as a starting dose or for patients requiring a lower dosage due to renal or hepatic impairment, sensitivity, or side effects at higher doses. Silofast 4 mg provides effective symptom relief while minimizing the risk of systemic side effects such as low blood pressure.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Silodosin 4 mg per capsule
Silofast acts by selectively blocking alpha-1A adrenergic receptors located predominantly in the prostate and bladder neck:
Relaxes smooth muscles in the prostate, bladder neck, and urethra
Reduces resistance to urinary flow
Improves urine passage and alleviates urinary hesitancy and incomplete emptying
Maintains blood pressure stability due to selective alpha-1A receptor targeting
This selectivity allows for effective management of BPH symptoms while reducing cardiovascular side effects commonly seen with non-selective alpha blockers.
Silofast Capsule 4 mg is indicated for:
Treatment of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)
Improvement of urinary flow rate and reduction of obstructive urinary symptoms
Relief of urinary hesitancy, straining, weak stream, and nocturia
Patients requiring a lower starting dose due to sensitivity or mild renal/hepatic impairment
The recommended dose is 4 mg once daily, preferably after a meal to enhance absorption.
Swallow the capsule whole with water; do not crush or chew.
Take at the same time every day for consistent symptom control.
Dose may be adjusted to 8 mg once daily depending on response and tolerability under physician guidance.
Patients with moderate renal or hepatic impairment should use the 4 mg dose unless otherwise advised.
Provides effective relief from urinary obstruction and LUTS
Improves urinary flow and reduces straining during urination
Reduces symptoms such as urgency, frequency, and nocturia
Selective alpha-1A receptor blockade minimizes systemic blood pressure effects
Enhances quality of life in patients with BPH
Use cautiously in patients with severe renal or hepatic impairment
Monitor patients with a history of orthostatic hypotension, cardiovascular disorders, or concurrent antihypertensive therapy
Avoid abrupt discontinuation; follow physician guidance
Consult a healthcare provider before use in elderly patients or those with multiple health conditions
Common side effects include:
Dizziness or lightheadedness, especially on standing
Retrograde ejaculation (usually reversible upon discontinuation)
Nasal congestion
Headache
Mild gastrointestinal disturbances, such as diarrhea or nausea
Rare but serious side effects:
Severe hypotension
Allergic reactions including rash or swelling
Store below 30°C in a dry, cool place, away from direct sunlight and moisture. Keep out of reach of children.
Silofast Capsule 4 mg provides effective, low-dose management of BPH symptoms through selective alpha-1A receptor blockade, improving urine flow, relieving urinary discomfort, and enhancing daily life for men with benign prostatic hyperplasia.
Login Or Registerto submit your questions to seller
No none asked to seller yet